You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (ii) Distribution of new outpatient clients by primary drug for each age group

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Age known	Age not known
Opioids	3.2	12.7	30.9	39.1	45.4	49.5	51.9	47.3	45861	2277
Cocaine	2.3	10.7	21.2	29.4	31.8	30.0	29.0	22.6	30813	278
Stimulants	4.3	6.4	5.2	3.9	3.4	3.1	2.3	1.7	5340	23
Hypnotics and sedatives	0.8	1.1	1.0	1.2	1.9	2.4	3.1	10.5	2547	37
Hallucinogens	0.2	0.3	0.2	0.2	0.1	0.1	0.0	0.1	230	3
Volatile substances	7.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	418	1
Cannabis	80.0	67.0	40.2	25.0	15.8	13.2	11.6	12.6	40255	458
Other substances	2.2	1.0	1.2	1.2	1.5	1.6	2.0	5.2	1964	80
Total	1921	19817	29991	25822	19824	14192	8749	7112	127428	3157

Notes:

The countries supplying data are:

BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, LT, HU, MT, NL, PT, SK, FI, SE, UK

Last data available from Spain refer to year of treatment 2004.

The number of treatment clients in each country is listed in [Table TDI-7].

See also 'TDI-102-New outpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI outpatient treatment centres.